Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
12°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Altasciences
Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity
November 21, 2024
From
Altasciences
Via
Business Wire
Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services
November 13, 2024
From
Altasciences
Via
Business Wire
Altasciences’ Chief Scientific Officer Named a PharmaVoice 100 Honoree
October 09, 2024
From
Altasciences
Via
Business Wire
Altasciences Receives 2024 CRO Leadership Award for Capabilities
May 29, 2024
From
Altasciences
Via
Business Wire
Altasciences Appoints New General Manager, Clinical Operations
January 29, 2024
From
Altasciences
Via
Business Wire
Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri
October 31, 2023
From
Altasciences
Via
Business Wire
Angel Reyes Joins Altasciences as General Manager of CDMO Services
October 06, 2023
From
Altasciences
Via
Business Wire
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
September 21, 2023
From
Altasciences
Via
Business Wire
Tickers
VRPX
Altasciences Completes Successful Phase I Trial of Ischemix’ Novel Compound for Treatment of Traumatic Brain Injury (TBI)
August 30, 2023
From
Altasciences
Via
Business Wire
Altasciences Receives 2023 CRO Leadership Award for Capabilities
May 09, 2023
From
Altasciences
Via
Business Wire
Altasciences Completes Clinical Portion of Alzamend Neuro’s Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer’s
April 18, 2023
From
Altasciences
Via
Business Wire
Altasciences Receives Accreditation From College of American Pathologists
October 31, 2022
From
Altasciences
Via
Business Wire
Altasciences Expands Laboratory Capabilities in Columbia
October 19, 2022
From
Altasciences
Via
Business Wire
Altasciences Expands Strategic Support for Early Drug Development in Europe and Adds Key Employees to Its Preclinical Team in North America
October 14, 2022
From
Altasciences
Via
Business Wire
Altasciences Continues Manufacturing Expansion in Philadelphia With Client‑Dedicated Building Project
July 15, 2022
From
Altasciences
Via
Business Wire
Altasciences Receives CRO Leadership Award in Five Categories
May 30, 2022
From
Altasciences
Via
Business Wire
Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology
February 07, 2022
From
Altasciences
Via
Business Wire
Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform
January 04, 2022
From
Altasciences
Via
Business Wire
Altasciences Chosen by Respira Technologies, Inc. as Drug Product Manufacturing Partner for the World’s First Inhaled Nicotine Replacement Therapy (NRT)
December 14, 2021
From
Altasciences
Via
Business Wire
Altasciences Chosen by XORTX Therapeutics, Inc. to Conduct Pharmacokinetic Bridging Study XRX-OXY-101 in Support of Developing New Therapies for Progressive Kidney Disease and Acute Kidney Injury
December 09, 2021
From
Altasciences
Via
Business Wire
Altasciences Expands Ligand Binding Laboratory to Meet High Demand for Bioanalytical Solutions
November 23, 2021
From
Altasciences
Via
Business Wire
Altasciences Continues Building Expansion with Additional Location in Philadelphia
September 27, 2021
From
Altasciences
Via
Business Wire
Bruce Frank Joins Altasciences as Vice President, CDMO Operations
August 13, 2021
From
Altasciences
Via
Business Wire
Altasciences Initiates Phase I Study in Healthy Normal Subjects for ST-2427, a Non-Opioid Analgesic for Acute Pain
May 13, 2021
From
Altasciences
Via
Business Wire
Altasciences Acquires Calvert Laboratories
May 05, 2021
From
Altasciences
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.